Immunity requires the random assembly of a diverse repertoire of immune receptors during lymphocyte development, many of which are self-reactive. To prevent autoimmunity, self-reactive lymphocytes are eliminated in central lymphoid organs during development. However, central tolerance mechanisms are not sufficient to veto all of the autoreactivity. In the first funding period of this program project award we developed a means to specifically target antigens to a subset of dendritic cells (DCs) that express the DEC- 205 antigen (CD8+DEC205+DCs) in vivo and showed that the steady state function of these cells is to maintain tolerance by inducing T cell deletion, or anergy or by facilitating the development of regulatory T cells. In preliminary experiments we have extended this antigen delivery method to a second group of DCs (CD8-33D1+DCs) that represent most of the DCs in mouse spleen. We find a novel form of regulation of antigen processing and presentation by DCs in vivo not anticipated by in vitro studies. CD8+DEC205+DCs are specialized for intracellular retention of immunologically intact antigen and presentation on MHCI, whereas CD8-33D1+DCs rapidly process the same antigen for presentation by MHCIL The long-range goals of this proposal are to determine how the two DC subsets contribute to maintaining self-tolerance and to exploit differences between the subsets in the prevention and therapy of autoimmunity. To accomplish these goals we propose to determine the cellular and molecular basis for the observed differences in antigen processing and presentation by the two subsets and to compare the two DC subsets in induction of T cell deletion, anergy and regulatory T cells. The working hypothesis is that the two DCsubsets will have unique and complementary functions in maintaining tolerance in vivo.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Program Projects (P01)
Project #
5P01AI051573-08
Application #
7905129
Study Section
Special Emphasis Panel (ZAI1)
Project Start
Project End
Budget Start
2009-07-01
Budget End
2010-06-30
Support Year
8
Fiscal Year
2009
Total Cost
$374,806
Indirect Cost
Name
Rockefeller University
Department
Type
DUNS #
071037113
City
New York
State
NY
Country
United States
Zip Code
10065
Sela, Uri; Park, Chae Gyu; Park, Andrew et al. (2016) Dendritic Cells Induce a Subpopulation of IL-12R?2-Expressing Treg that Specifically Consumes IL-12 to Control Th1 Responses. PLoS One 11:e0146412
Guermonprez, Pierre; Helft, Julie; Claser, Carla et al. (2013) Inflammatory Flt3l is essential to mobilize dendritic cells and for T cell responses during Plasmodium infection. Nat Med 19:730-8
Schreiber, Heidi A; Loschko, Jakob; Karssemeijer, Roos A et al. (2013) Intestinal monocytes and macrophages are required for T cell polarization in response to Citrobacter rodentium. J Exp Med 210:2025-39
Bozzacco, Leonia; Yu, Haiqiang (2013) Identification and quantitation of MHC class II-bound peptides from mouse spleen dendritic cells by immunoprecipitation and mass spectrometry analysis. Methods Mol Biol 1061:231-43
Bozzacco, Leonia; Yu, Haiqiang; Dengjel, Jorn et al. (2012) Strategy for identifying dendritic cell-processed CD4+ T cell epitopes from the HIV gag p24 protein. PLoS One 7:e41897
Meredith, Matthew M; Liu, Kang; Kamphorst, Alice O et al. (2012) Zinc finger transcription factor zDC is a negative regulator required to prevent activation of classical dendritic cells in the steady state. J Exp Med 209:1583-93
Meredith, Matthew M; Liu, Kang; Darrasse-Jeze, Guillaume et al. (2012) Expression of the zinc finger transcription factor zDC (Zbtb46, Btbd4) defines the classical dendritic cell lineage. J Exp Med 209:1153-65
Wang, Bei; Zaidi, Neeha; He, Li-Zhen et al. (2012) Targeting of the non-mutated tumor antigen HER2/neu to mature dendritic cells induces an integrated immune response that protects against breast cancer in mice. Breast Cancer Res 14:R39
Bozzacco, Leonia; Yu, Haiqiang; Zebroski, Henry A et al. (2011) Mass spectrometry analysis and quantitation of peptides presented on the MHC II molecules of mouse spleen dendritic cells. J Proteome Res 10:5016-30
Li, Fubin; Ravetch, Jeffrey V (2011) Inhibitory Fc? receptor engagement drives adjuvant and anti-tumor activities of agonistic CD40 antibodies. Science 333:1030-4

Showing the most recent 10 out of 40 publications